• Katie Thomson, Frances Hillier-Brown, Nick Walton, Mirza Bilaj, Clare Bambra, and Adam Todd.
• Institute of Health and Society, Faculty of Medical Sciences, Newcastle University, Baddiley-Clark Building, Newcastle upon Tyne NE2 4AX, UK; Fuse - the UKCRC Centre for Translational Research in Public Health, UK. Electronic address: katie.thomson@newcastle.ac.uk.
• Prev Med. 2019 Jul 1; 124: 98-109.

AbstractCommunity pharmacies have great potential to deliver services aimed at promoting health and preventing disease, and are well placed in deprived communities. This review of reviews aimed to assess the effectiveness of community pharmacy-delivered public health services and assess how they impact on inequalities in health using PROGRESS-Plus characteristics. Twenty databases were searched from their start date until January 2018. The quality of the included articles was determined using the Assessment of Multiple Systematic Reviews tool (AMSTAR 2). Fifteen systematic reviews were identified reporting 157 unique primary studies. There were a number of community pharmacy initiatives with positive intervention effects on health outcomes. These services were predominantly focused on primary disease prevention, and included smoking cessation, weight management programmes, syringe exchange programmes, and inoculation services. This review supports the development of some community pharmacy public health services. At present, little is known how community pharmacy-delivered public health interventions impact on health inequalities. It would be prudent for future studies to address this by explicitly reporting outcomes according to the PROGRESS-Plus framework. SYSTEMATIC REVIEW REGISTRATION: PROSPERO registration number: CRD42017056264.Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

11 keywords...

hide…